Carlo
PeopleProgramsSpecialtiesInstitutionsPricing
Sign inJoin waitlistJoin the waitlist
Carlo

the ai that helps you match

Part of the Carlo family
© 2026 Carlo Finance, Inc.
PeopleProgramsSpecialtiesInstitutionsPricingMethodologyPrivacyTerms
Back to overview

University of California Davis Health Gynecologic Oncology

Fellowship · Sacramento, CA

Sponsored by University of California Davis Health · Director Rebecca Brooks

Research

Works by its people
282
Authors
28
First-author works
68
Citations
13,184
20112026

Topics

  • Endometrial and Cervical Cancer Treatments 51
  • Ovarian cancer diagnosis and treatment 38
  • Cervical Cancer and HPV Research 12
  • Glycosylation and Glycoproteins Research 10
  • PARP inhibition in cancer therapy 6
  • Cancer Risks and Factors 5
  • Functional Brain Connectivity Studies 5
  • Cancer survivorship and care 4
  • Dendrimers and Hyperbranched Polymers 4
  • Gestational Trophoblastic Disease Studies 4
  • Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes 3
  • Cancer Genomics and Diagnostics 3

Most cited

  1. Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology.

    Journal of the National Comprehensive Cancer Network : JNCCN · 2023 · 486 citations · Rebecca Brooks

  2. Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer.

    The New England journal of medicine · 2023 · 633 citations · Eugenia Girda

  3. NCCN Guidelines® Insights: Cervical Cancer, Version 1.2024.

    Journal of the National Comprehensive Cancer Network : JNCCN · 2023 · 349 citations · Rebecca Brooks

  4. NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022.

    Journal of the National Comprehensive Cancer Network : JNCCN · 2022 · 346 citations · Gary Leiserowitz

  5. NCCN Guidelines® Insights: Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024.

    Journal of the National Comprehensive Cancer Network : JNCCN · 2024 · 127 citations · Gary Leiserowitz

  6. Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers.

    ESMO open · 2022 · 289 citations · Eugenia Girda

  7. Vulvar Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology.

    Journal of the National Comprehensive Cancer Network : JNCCN · 2024 · 85 citations · Rebecca Brooks

  8. NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2025.

    Journal of the National Comprehensive Cancer Network : JNCCN · 2025 · 55 citations · Rebecca Brooks